Long-term follow-up of HER2 overexpression in patients with rectal cancer after preoperative radiotherapy: A prospective cohort study

doi:10.4251/wjgo.v14.i10.2048

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3979)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

118

WORD

HTML

1265

Figures (1-2)

263

Tables (1-4)

179

Sum=1861

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

220

Download

732

Sum=952

Publishing Process of This Article

Item

Count

Browse

308

Download

858

Sum=1166

Oct 15, 2022 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2048-2060
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2048

Open in New Tab Full Size Figure Download Figure

Figure 1 Flowchart of cohorts and the distribution of HER2 expression. FISH: Fluorescence in situ hybridization.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier survival analysis of disease-free survival and overall survival rates in relation to HER2 status. A: HER2 overexpression in rectal cancers is correlated with a shorter disease-free survival, P = 0.048; B: HER2 overexpression in rectal cancers is correlated with a shorter overall survival, P = 0.0077. DFS: Disease-free survival; OS: Overall survival.

Citation: Chen N, Li CL, Peng YF, Yao YF. Long-term follow-up of HER2 overexpression in patients with rectal cancer after preoperative radiotherapy: A prospective cohort study. World J Gastrointest Oncol 2022; 14(10): 2048-2060
URL: https://www.wjgnet.com/1948-5204/full/v14/i10/2048.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.2048